Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We advised Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Live Nation Entertainment $1.1 billion convertible senior notes offering
The 2.875% convertible notes are due 2030
Comcast Business acquisition of Nitel from Cinven
We are advising Comcast Business on the acquisition
Gruma $800 million senior notes offering
The notes are due 2034 and 2054
J.F. Lehman closes $2.2 billion Fund VI
We advised J.F. Lehman on the fundraise and related matters
IREN $440 million convertible notes offering
We advised IREN on the offering
MoneyLion $1 billion acquisition by Gen Digital
We are advising MoneyLion on the acquisition
Amer Sports $1.05 billion follow-on offering
We advised Amer Sports on its SEC-registered offering
Revolution Medicines $750 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
PG&E $2.76 billion common and preferred share offerings
The common stock is, and the preferred stock will be, listed on the NYSE
indie Semiconductor $218.5 million convertible senior notes offering
The 3.5% convertible senior notes are due 2029